Atlas Trials

Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment

Clinical trial NCT04321161 · COMPLETED

Trial details

NCT number
NCT04321161
Sponsor
University of Freiburg
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia, in Relapse
Start date
2020-02-25
Primary completion
2020-03-18
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.